Hillman Cancer Institute at UPMC

Pittsburgh, Pennsylvania 15232

0 studies enrolling now · 2 studies all time

What they study most

Mantle Cell Lymphoma, Myelodysplastic Syndromes

Studies at this site

• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes — Completed
• A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial — Completed